Institute of Biomedical Research (OTCMKTS:MRES) Stock Gains Following a Key Update
If you are currently looking into innovative companies then it could be a good time to keep track of the South African Bioceutical firm – Institute of Biomedical Research (OTCMKTS:MRES). The company is focused on the development of alternative plant-based CBDs and therapeutic research into mental health issues.
M2Bio Appoints Ze-ev Krein as Chairman of the M2Bio Scientific Advisory Board
Last week on April 6 the company provided a key update with regard to the appointment of the Chairman of its Scientific Advisory Board. The position was accepted by Ze-evKrein. The Scientific Advisory Board is a highly important position for a company that is involved in innovation and the position of the chairman of that board is also highly important.
In its press release, the company announced that Krein is a highly experienced professional with years of experience in drug development, legislation, computer science, and analytical chemistry. Institute of Biomedical Research further noted that his presence will be of immense value in providing the scientific advisory board with the right guidance with regard to the development of novel approaches for innovation and growth. Krein went to the University of Cape Town and graduated with a Bachelors’s in Commerce degree in information systems.